Clinical outcomes of pediatric Anti-NMDA receptor encephalitis
- 1 November 2020
- journal article
- research article
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 29, 87-91
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitisNeurology, 2018
- Antibody-Mediated EncephalitisNew England Journal of Medicine, 2018
- N‐methyl‐d‐aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regressionDevelopmental Medicine & Child Neurology, 2016
- N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in childrenArchives of Disease in Childhood, 2015
- Anti–N-Methyl-D-Aspartate (NMDA) Receptor EncephalitisJournal of Child Neurology, 2013
- Pediatric Anti-N-methyl-D-Aspartate Receptor Encephalitis—Clinical Analysis and Novel Findings in a Series of 20 PatientsThe Journal of Pediatrics, 2013
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Anti-N-Methyl-d-aspartate-receptor encephalitis: Cognitive profile in two childrenEuropean Journal of Paediatric Neurology, 2012
- Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescentsAnnals of Neurology, 2009
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007